Fig. 3 | Scientific Reports

Fig. 3

From: Immunogenicity and safety of CoronaVac vaccine in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up

Fig. 3

Kinetics of total IgG anti-S (A) and anti-N (B) antibody levels to SARS-CoV-2 at pre-vaccination, 1 month after the first dose, and 1, 3, and 6 months after receiving the second dose of CoronaVac separately for age groups (3–11 and 12–17 years old). The detection limit of 0.1508 in (A) and 0.1460 in (B) is represented by dashed lines. The colored dots represent the geometric mean of optical density (450 nm) for each vaccinated age group.

Back to article page